Abdominal MRI-Derived Liver, Visceral Fat, and Pancreatic Phenotypes Improve Prediction of Incident Type 2 Diabetes.

Authors

Ruotong Peng, Xuyang Diao, Yiwen Dai, Jingxin Chen, Linqing Zhu, Menghan Zhu, Xinqing Yang, Yang Pan, Yuling Liu, Darui Gao, Yanyu Zhang, Mengmeng Ji, Wuxiang Xie, Fanfan Zheng

Published in

Diabetes/metabolism research and reviews. Volume 42. Issue 7. Pages e70235.

Abstract

To evaluate whether abdominal magnetic resonance imaging (MRI)-derived metabolic phenotypes improve the opportunistic prediction of incident type 2 diabetes (T2D) beyond clinical risk models.
This study included 36,833 UK Biobank participants who underwent abdominal MRI and were free of T2D at imaging baseline. The original Cambridge Diabetes Risk Score (CDRS) was evaluated, and glycated haemoglobin (HbA1c) was added to form the clinical CDRS model. MRI phenotypes were selected using a LASSO-based selection-frequency analysis and added to construct the clinical CDRS-MRI model. Model performance was assessed in an internal validation set using Harrell's C-index, continuous net reclassification improvement (NRI), and integrated discrimination improvement (IDI).
During a median follow-up of 7.38 years, 570 participants developed incident T2D. The selection-frequency analysis retained four MRI phenotypes: liver proton density fat fraction, liver volume, visceral fat volume, and pancreas volume. In the internal validation set, C-indices were 0.765 (95% CI, 0.731-0.800) for the original CDRS model, 0.820 (95% CI, 0.786-0.849) for the clinical CDRS model, and 0.849 (95% CI, 0.818-0.877) for the clinical CDRS-MRI model. The clinical CDRS-MRI model improved the C-index by 0.084 versus the original CDRS model and by 0.029 versus the clinical CDRS model, with a continuous NRI of 56.2% (95% CI, 40.6%-70.0%) and an IDI of 0.022 (95% CI, 0.010-0.037).
Abdominal MRI-derived phenotypes improved the prediction of incident T2D beyond established clinical risk models. These findings support secondary use of available abdominal MRI data for metabolic risk stratification, pending external validation.

PMID:
42823755
Bibliographic data and abstract were imported from PubMed on 02 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.